🏠

Levemir®.
RX Navigator

Interactive safety profile visualization for Levemir® (insulin detemir), based on the official Summary of Product Characteristics

Patient Data

Age (years)

Minimum age for use: 1 year.

Weight (kg)

Diabetes type: Type 1 Type 2

Insulin administration method: Pen / Syringe Insulin pump

Clinical Situation and Conditions

Renal impairment Hepatic impairment Hypoglycaemia risk factors present Acute infection or concomitant illness Endocrine gland diseases Severe hypoalbuminaemia Pregnancy or planning pregnancy Breast-feeding Risk factors for cardiac failure (with pioglitazone) History of allergy to Levemir Lipodystrophy or cutaneous amyloidosis Transferring from another insulin Used in basal-bolus regimen

Concomitant Medications and Substances

Starting a GLP-1 receptor agonist Taking OADs / GLP-1 receptor agonists MAO inhibitors Beta-blockers ACE inhibitors / Salicylates etc. Drugs increasing insulin requirements Octreotide / Lanreotide Pioglitazone Alcohol consumption

*according to the official Summary of Product Characteristics

Risk Factors

Key Information from SmPC:

This tool is intended for informational purposes only. It is not a medical device and is not designed for diagnosis, treatment prescription, or clinical decision-making. The information provided does not replace a thorough review of the official prescribing information for the medicinal product and should not be used as a substitute for the professional judgment of a physician or pharmacist.

Levemir®. RX Navigator

Risk Factors

Key Information from SmPC:

Levemir®.
RX Navigator